img

The ???Uber of Biotech??? Gets Back To Work

Hilary Kramer discusses biotech stocks, outlines their risks and compares the industry leader to Uber.

  • by:
  • 08/21/2022
ad-image

By Hilary Kramer

Forget the ???FANG??? group of the biggest technology companies. When you want pure disruptive innovation and a wild Wall Street ride, biotech remains the place to be.

I love these stocks. When they???re rallying, they???re a play on pure innovation. This is because they generate wealth for shareholders on what boils down to the confidence that medical science will keep advancing.

The upside is practically infinite. After all, most computer tools only improve life in increments, make us a little more productive day by day and expand our existing reach.

Biotech, at its most visionary, saves human lives that otherwise would be cut short one way or another. That transcends normal valuations.

Companies that develop those therapies can one day be worth the price of progress itself. And when that mood catches on, the stocks soar.

We???ve seen a few of these stocks on my Turbo Trader list soar 50 percent year to date. That???s true transformative upside. It???s exhilarating.

Click here to read more.

Image:

Opinion

View All

ALLUM BOKHARI to JACK POSOBIEC: The 'permanent bureaucracy' wants to control AI tech because it's 'undermining their power'

"The underlying technology, be it social media, be it AI, is trending towards the disruption of the e...

UK to seize homes that have been empty for six months

The move is in an effort to “ensure existing housing stock is used more effectively.”...

JULIO RIVERA: Why we shouldn't regulate AI into submission

The important security question is not whether AI is intelligent. It is whether its authority is prop...

Hero pilot who saved Tel Aviv-bound passengers during attempted hijacking speaks to PM Modi

" I told everyone that I was doing it based on my own life. But at the same time, I also knew that I ...